REgistry on Real-Life EXperience With Left Atrial Appendage Occlusion

REgistry on Real-Life EXperience With Left Atrial Appendage Occlusion for Patients With Atrial Fibrillation in France

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03279406

Acronym

RELEXAO

Enrollment

400

Registered

2017-09-12

Start date

2012-02-01

Completion date

2018-09-01

Last updated

2024-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

Atrial fibrillation, Stroke, Thrombus, Left atrial appendage, Bleeding

Brief summary

The objective of this observational non-randomized multicenter study is to compile real-world clinical characteristics and outcomes data for patients treated with LAA (left atrial appendage) closure systems in a daily clinical setting.

Interventions

DEVICEPercutaneous Left Atrial Appendage Occlusion

Percutaneous left atrial appendage occlusion in routine care for patients with atrial fibrillation

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Inclusion criteria

* Patients who are eligible for a LAA occlusion device and treated with a commercially available device according to international and local guidelines and per physician discretion.

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame	Description
Major adverse cardiovascular events	From date of inclusion until the date of first documented event, whichever came first, assessed up to 60 months	Death, Ischemic stroke, Transient ischemic attack, Major hemorrhage, Thrombus on device

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026